Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis
We investigated the effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis for 3 and 5 years. Significant improvement found the decrease of the frequency of clinical exacerbations and delay the accumulation of physical disability during treatment period.
Hlavní autoři: | V. M. Alifirova, M. A. Titova, A. A. Vereschaka |
---|---|
Médium: | Článek |
Jazyk: | English |
Vydáno: |
Siberian State Medical University (Tomsk)
2010-08-01
|
Edice: | Бюллетень сибирской медицины |
Témata: | |
On-line přístup: | https://bulletin.ssmu.ru/jour/article/view/1618 |
Podobné jednotky
-
Copaxone in therapy of remittent disseminated sclerosis patients
Autor: O. A. Kitcherova, a další
Vydáno: (2008-09-01) -
Epidemiological characteristics of multiple sclerosis in Tomsk Region and their dynamics for last 30 years
Autor: V. M. Alifirova, a další
Vydáno: (2012-06-01) -
Prospects of laboratory risk evaluation of multiple sclerosis relapse and progressing
Autor: I. V. Smagina, a další
Vydáno: (2010-08-01) -
ATYPICAL FORMS OF MULTIPLE SCLEROSIS IN THE TOMSK REGION
Autor: V. M. Alifirova, a další
Vydáno: (2013-10-01) -
Cognitive disturbances in patients with multiple sclerosis
Autor: V. M. Alifirova, a další
Vydáno: (2008-09-01)